UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PRESERVATION OF OVARIAN FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY.

被引：0
|
作者：
Vitez, Sally F. [1 ]
Chen, Ling [1 ]
Brady, Paula C. [1 ]
Wright, Jason D. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
FERTILITY AND STERILITY | 2019年 / 112卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2019.07.412
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-9
引用
收藏
页码：E112 / E112
页数：1
相关论文
共 50 条
  • [31] Potential Late Effect of Gonadotropin-Releasing Hormone Agonists in Combination With Chemotherapy for Early Breast Cancer Reply
    Munster, Pamela N.
    Moore, Amy P.
    Ismail-Khan, Roohi
    Cox, Charles E.
    Lacevic, Mensura
    Gross-King, Margaret
    Xu, Ping
    Carter, W. Bradford
    Minton, Susan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3312 - 3313
  • [32] Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis
    Ejaz, Komal
    Abid, Dania
    Juneau, Paul
    Chu, Jun
    Hasni, Sarfaraz
    LUPUS, 2022, 31 (14) : 1706 - 1713
  • [33] Use of Gonadotropin-releasing Hormone Agonists for Ovarian Preservation in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus: A Meta-analysis
    Ejaz, Komal
    Abid, Dania
    Juneau, Paul
    Chu, Jun
    Hasni, Sarfaraz
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1912 - 1914
  • [34] Gonadotropin-releasing hormone agonists in the treatment of prostate cancer
    Labrie, F
    Bélanger, A
    Luu-The, V
    Labrie, C
    Simard, J
    Cusan, L
    Gomez, J
    Candas, B
    ENDOCRINE REVIEWS, 2005, 26 (03) : 361 - 379
  • [35] Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis
    Senra, J. C.
    Roque, M.
    Talim, M. C. T.
    Reis, F. M.
    Tavares, R. L. C.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (01) : 77 - 86
  • [36] Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients
    Lee, D. Y.
    Mok, C. W.
    Choi, D.
    HUMAN REPRODUCTION, 2017, 32 : 373 - 373
  • [37] Is gonadotropin-releasing hormone analogue effective to preserve ovarian function in women undergoing chemotherapy for gynecologic malignancies?
    Lee, K. B.
    Lim, S.
    Choi, M. C.
    Lee, J. M.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 260 - 260
  • [38] Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain
    Turner, N. H.
    Partridge, A.
    Sanna, G.
    Di Leo, A.
    Biganzoli, L.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2224 - 2235
  • [39] Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer
    Chung, Shiu-Dong
    Liu, Shih-Ping
    Lin, Herng-Ching
    Wang, Li-Hsuan
    PLOS ONE, 2014, 9 (06):
  • [40] Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
    Shen, Yan-Wei
    Zhang, Xiao-Man
    Lv, Meng
    Chen, Ling
    Qin, Tian-Jie
    Wang, Fan
    Yang, Jiao
    Liu, Pei-Jun
    Yang, Jin
    ONCOTARGETS AND THERAPY, 2015, 8 : 2349 - 2359
12345